Exploring bioactive properties of marine cyanobacteria isolated from the Portuguese coast: High potential as a source of anticancer compounds

Marine Drugs

Volumn 12, Issue 1, 2014, Pages 98-114

  Costa, Margarida ^a   Garcia, Mónica ^b   Costa Rodrigues, João ^b   Costa, Maria Sofia ^a   Ribeiro, Maria João ^a   Fernandes, Maria Helena ^b   Barros, Piedade ^c   Barreiro, Aldo ^a   Vasconcelos, Vitor ^a,d   Martins, Rosaŕio ^a,c,e  

^a UNIVERSITY OF PORTO   (Portugal)

^b U Porto   (Portugal)

^c POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

^e UNIVERSITY OF PORTO   (Portugal)

Author keywords

Anticancer potential; Marine cyanobacteria; Natural products

Indexed keywords

ANTINEOPLASTIC AGENT; MARINE CYANOBACTERIA EXTRACT; METHANOL; NATURAL PRODUCT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIOLOGICAL ACTIVITY; CANCER CELL; CELL VIABILITY; COASTAL WATERS; CONTROLLED STUDY; CYANOBACTERIUM; CYANOBIUM; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; LEPTOLYNGBYA; MARINE BACTERIUM; NODOSILINEA; NONHUMAN; NUCLEOTIDE SEQUENCE; PICOPLANKTON; PORTUGAL; PSEUDANABAENA; ROMERIA; SYNECHOCOCCUS; SYNECHOCYSTIS;

ANTINEOPLASTIC AGENTS; ATLANTIC OCEAN; BIOLOGICAL PRODUCTS; CELL LINE, TUMOR; COLORING AGENTS; CYANOBACTERIA; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; L-LACTATE DEHYDROGENASE; MARINE TOXINS; PORTUGAL; SPECIES SPECIFICITY; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84892877857     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md12010098     Document Type: Article

References (46)

1. Butler, M.S. The role of natural product chemistry in drug discovery. J. Nat. Prod. 2004, 67, 2141-2153.
2. Li, J.W.; Vederas, J.C. Drug discovery and natural products: End of an era or an endless frontier? Science 2009, 325, 161-165.
3. Nagarajan, M.; Maruthanayagam, V.; Sundararaman, M. A review of pharmacological and toxicological potentials of marine cyanobacterial metabolites. J. Appl. Toxicol. 2012, 32, 153-185.
4. Jimenez, J.I.; Vansach, T.; Yoshida, W.Y.; Sakamoto, B.; Porzgen, P.; Horgen, F.D. Halogenated fatty acid amides and cyclic depsipeptides from an eastern Caribbean collection of the cyanobacterium Lyngbya majuscula. J. Nat. Prod. 2009, 72, 1573-1578.
5. Gutierrez, M.; Tidgewell, K.; Capson, T.L.; Engene, N.; Almanza, A.; Schemies, J.; Jung, M.; Gerwick, W.H. Malyngolide dimer, a bioactive symmetric cyclodepside from the panamanian marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 2010, 73, 709-711.
6. Tripathi, A.; Puddick, J.; Prinsep, M.R.; Rottmann, M.; Chan, K.P.; Chen, D.Y.; Tan, L.T. Lagunamide C, a cytotoxic cyclodepsipeptide from the marine cyanobacterium Lyngbya majuscula. Phytochemistry 2011, 72, 2369-2375.
7. Malloy, K.L.; Villa, F.A.; Engene, N.; Matainaho, T.; Gerwick, L.; Gerwick, W.H. Malyngamide 2, an oxidized lipopeptide with nitric oxide inhibiting activity from a Papua New Guinea marine cyanobacterium. J. Nat. Prod. 2011, 74, 95-98.
8. Mevers, E.; Liu, W.T.; Engene, N.; Mohimani, H.; Byrum, T.; Pevzner, P.A.; Dorrestein, P.C.; Spadafora, C.; Gerwick, W.H. Cytotoxic veraguamides, alkynyl bromide-containing cyclic depsipeptides from the marine cyanobacterium cf. Oscillatoria margaritifera. J. Nat. Prod. 2011, 74, 928-936.
9. Gutierrez, M.; Suyama, T.L.; Engene, N.; Wingerd, J.S.; Matainaho, T.; Gerwick, W.H. Apratoxin D, a potent cytotoxic cyclodepsipeptide from papua new guinea collections of the marine cyanobacteria Lyngbya majuscula and Lyngbya sordida. J. Nat. Prod. 2008, 71, 1099-1103.
10. Han, B.; Gross, H.; Goeger, D.E.; Mooberry, S.L.; Gerwick, W.H. Aurilides B and C, cancer cell toxins from a Papua New Guinea collection of the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 2006, 69, 572-575.
11. Mooberry, S.L.; Leal, R.M.; Tinley, T.L.; Luesch, H.; Moore, R.E.; Corbett, T.H. The molecular pharmacology of symplostatin 1: A new antimitotic dolastatin 10 analog. Int. J. Cancer 2003, 104, 512-521.
12. Medina, R.A.; Goeger, D.E.; Hills, P.; Mooberry, S.L.; Huang, N.; Romero, L.I.; Ortega-Barria, E.; Gerwick, W.H.; McPhail, K.L. Coibamide A, a potent antiproliferative cyclic depsipeptide from the Panamanian marine cyanobacterium Leptolyngbya sp. J. Am. Chem. Soc. 2008, 130, 6324-6325.
13. Rubio, B.K.; Parrish, S.M.; Yoshida, W.; Schupp, P.J.; Schils, T.; Williams, P.G. Depsipeptides from a Guamanian marine cyanobacterium, Lyngbya bouillonii, with Selective Inhibition of Serine Proteases. Tetrahedron Lett. 2010, 51, 6718-6721.
14. Chen, X.X.; Smith, G.D.; Waring, P. Human cancer cell (Jurkat) killing by the cyanobacterial metabolite calothrixin A. J. Appl. Phycol. 2003, 15, 269-277.
15. Luesch, H.; Yoshida, W.Y.; Moore, R.E.; Paul, V.J.; Mooberry, S.L. Isolation, structure determination, and biological activity of Lyngbyabellin A from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 2000, 63, 611-615.
16. Kalemkerian, G.P.; Ou, X.L.; Adil, M.R.; Rosati, R.; Khoulani, M.M.; Madan, S.K.; Pettit, G.R. Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: Induction of apoptosis and bcl-2 modification. Cancer Chemother. Pharmacol. 1999, 43, 507-515.
17. LePage, K.T.; Goeger, D.; Yokokawa, F.; Asano, T.; Shioiri, T.; Gerwick, W.H.; Murray, T.F. The neurotoxic lipopeptide kalkitoxin interacts with voltage-sensitive sodium channels in cerebellar granule neurons. Toxicol. Lett. 2005, 158, 133-139.
18. Gerwick, W.H.; Coates, R.; Engene, N.; Gerwick, L.; Grindberg, R.; Jones, A.C.; Sorrels, C.M. Giant marine cyanobacteria produce exciting potential pharmaceuticals. Microbe 2008, 3, 8.
19. Engene, N.; Choi, H.; Esquenazi, E.; Rottacker, E.C.; Ellisman, M.H.; Dorrestein, P.C.; Gerwick, W.H. Underestimated biodiversity as a major explanation for the perceived rich secondary metabolite capacity of the cyanobacterial genus Lyngbya. Environ. Microbiol. 2011, 13, 1601-1610.
20. Engene, N.; Rottacker, E.C.; Kastovsky, J.; Byrum, T.; Choi, H.; Ellisman, M.H.; Komarek, J.; Gerwick, W.H. Moorea producens gen. nov., sp. nov. and Moorea bouillonii comb. nov., tropical marine cyanobacteria rich in bioactive secondary metabolites. Int. J. Syst. Evol. Microbiol. 2012, 62, 1171-1178.
21. Taniguchi, M.; Nunnery, J.K.; Engene, N.; Esquenazi, E.; Byrum, T.; Dorrestein, P.C.; Gerwick, W.H. Palmyramide A, a cyclic depsipeptide from a Palmyra Atoll collection of the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 2010, 73, 393-398.
22. McPhail, K.L.; Correa, J.; Linington, R.G.; Gonzalez, J.; Ortega-Barria, E.; Capson, T.L.; Gerwick, W.H. Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 2007, 70, 984-988.
23. Matthew, S.; Paul, V.J.; Luesch, H., Largamides A-C, tiglic acid-containing cyclodepsipeptides with elastase-inhibitory activity from the marine cyanobacterium Lyngbya confervoides. Planta Med. 2009, 75, 528-533.
24. Thornburg, C.C.; Thimmaiah, M.; Shaala, L.A.; Hau, A.M.; Malmo, J.M.; Ishmael, J.E.; Youssef, D.T.; McPhail, K.L. Cyclic depsipeptides, grassypeptolides D and E and Ibu-epidemethoxylyngbyastatin 3, from a Red Sea Leptolyngbya cyanobacterium. J. Nat. Prod. 2011, 74, 1677-1685.
25. Teruya, T.; Sasaki, H.; Kitamura, K.; Nakayama, T.; Suenaga, K. Biselyngbyaside, a macrolide glycoside from the marine cyanobacterium Lyngbya sp. Org. Lett. 2009, 11, 2421-2424.
26. Bopp, S.K.; Lettieri, T. Comparison of four different colorimetric and fluorometric cytotoxicity assays in a zebrafish liver cell line. BMC Pharmacol. 2008, 8, 8.
27. Vaucher, R.A.; da Motta Ade, S.; Brandelli, A. Evaluation of the in vitro cytotoxicity of the antimicrobial peptide P34. Cell Biol. Int. 2010, 34, 317-323.
28. Kim, H.; Yoon, S.C.; Lee, T.Y.; Jeong, D. Discriminative cytotoxicity assessment based on various cellular damages. Toxicol. Lett. 2009, 184, 13-17.
29. Weyermann, J.; Lochmann, D.; Zimmer, A. A practical note on the use of cytotoxicity assays. Int. J. Pharm. 2005, 288, 369-376.
30. Plaza, M.; Santoyo, S.; Jaime, L.; Garcia-Blairsy Reina, G.; Herrero, M.; Senorans, F.J.; Ibanez, E. Screening for bioactive compounds from algae. J. Pharm. Biomed. Anal. 2010, 51, 450-455.
31. Leao, P.N.; Ramos, V.; Goncalves, P.B.; Viana, F.; Lage, O.M.; Gerwick, W.H.; Vasconcelos, V.M. Chemoecological screening reveals high bioactivity in diverse culturable portuguese marine cyanobacteria. Mar. Drugs 2013, 11, 1316-1335.
32. Hrouzek, P.; Tomek, P.; Lukesova, A.; Urban, J.; Voloshko, L.; Pushparaj, B.; Ventura, S.; Lukavsky, J.; Stys, D.; Kopecky, J. Cytotoxicity and secondary metabolites production in terrestrial Nostoc strains, originating from different climatic/geographic regions and habitats: Is their cytotoxicity environmentally dependent? Environ. Toxicol. 2011, 26, 345-358.
33. Mian, P.; Heilmann, J.; Burgi, H.R.; Sticher, O. Biological screening of terrestrial and freshwater cyanobacteria for antimicrobial activity, brine shrimp lethality, and cytotoxicity. Pharm. Biol. 2003, 41, 243-247.
34. Surakka, A.; Sihvonen, L.M.; Lehtimaki, J.M.; Wahlsten, M.; Vuorela, P.; Sivonen, K. Benthic cyanobacteria from the Baltic Sea contain cytotoxic Anabaena, Nodularia, and Nostoc strains and an apoptosis-inducing Phormidium strain. Environ. Toxicol. 2005, 20, 285-292.
35. Matthew, S.; Schupp, P.J.; Luesch, H. Apratoxin E, a cytotoxic peptolide from a guamanian collection of the marine cyanobacterium Lyngbya bouillonii. J. Nat. Prod. 2008, 71, 1113-1116.
36. Martins, R.; Pereira, P.; Welker, M.; Fastner, J.; Vasconcelos, V.M. Toxicity of culturable cyanobacteria strains isolated from the Portuguese coast. Toxicon 2005, 46, 454-464.
37. Frazao, B.; Martins, R.; Vasconcelos, V. Are known cyanotoxins involved in the toxicity of picoplanktonic and filamentous North Atlantic marine cyanobacteria? Mar. Drugs 2010, 8, 1908-1919.
38. Martins, R.; Fernandez, N.; Beiras, R.; Vasconcelos, V. Toxicity assessment of crude and partially purified extracts of marine Synechocystis and Synechococcus cyanobacterial strains in marine invertebrates. Toxicon 2007, 50, 791-799.
39. Martins, R.F.; Ramos, M.F.; Herfindal, L.; Sousa, J.A.; Skaerven, K.; Vasconcelos, V.M. Antimicrobial and cytotoxic assessment of marine cyanobacteria - Synechocystis and Synechococcus. Mar. Drugs 2008, 6, 1-11.
40. Lopes, V.R.; Schmidtke, M.; Fernandes, M.H.; Martins, R.; Vasconcelos, V. Cytotoxicity in L929 fibroblasts and inhibition of herpes simplex virus type 1 Kupka by estuarine cyanobacteria extracts. Toxicol. In Vitro 2011, 25, 944-950.
41. Kotai, J. Instructions for Preparation of Modified Nutrient Solution Z8 for Algae. NIVA B-11/69. NIVA 1976. Estimation of Algal Growth Potential; Norwegian Institute for Water Research: Oslo, Norway, 1972.
42. Rippka, R. Isolation and purification of cyanobacteria. Methods Enzymol. 1988, 167, 3-27.
43. Brito, A.; Ramos, V.; Seabra, R.; Santos, A.; Santos, C.L.; Lopo, M.; Ferreira, S.; Martins, A.; Mota, R.; Frazao, B.; et al. Culture-dependent characterization of cyanobacterial diversity in the intertidal zones of the Portuguese coast: A polyphasic study. Syst. Appl. Microbiol. 2012, 35, 110-119.
44. Costa, M.S.; Costa, M.; Ramos, V.; Leão, P.N.; Barreiro, A.; Vasconcelos, V.; Martins, R. Interdisciplinary Center of Marine and Environmental Research (CIIMAR/CIMAR), University of Porto, Porto, Portugal. Toxicity of Picocyanobacteria Isolates from a Clade of Marine Cyanobium. 2013, unpublished work.
45. Leao, P.N.; Costa, M.; Ramos, V.; Pereira, A.R.; Fernandes, V.C.; Domingues, V.F.; Gerwick, W.H.; Vasconcelos, V.M.; Martins, R. Antitumor activity of hierridin B, a cyanobacterial secondary metabolite found in both filamentous and unicellular marine strains. PLoS One 2013, 8, e69562.
46. Lopes, V.R.; Ramos, V.; Martins, A.; Sousa, M.; Welker, M.; Antunes, A.; Vasconcelos, V.M. Phylogenetic, chemical and morphological diversity of cyanobacteria from Portuguese temperate estuaries. Mar. Environ. Res. 2012, 73, 7-16.